This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.
We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.
SENSIGHT is the first data analytics platform to provide industrial scale access to anonymised and de-identified real world data insights globally across multiple therapy areas combined with built in simple to use research algorithms.
The platform is evolving rapidly adding researchable disease areas, analytical tools and patient data towards a planned data set of 100m patients by 2024.
SENSIGHT provides researchers across life sciences, healthcare and academia with an instant, artificial intelligence enabled research capability to harness the true potential of real-world data.
The platform achieves this by delivering a simple way to derive rapid insights and informed decisions from curated deep, longitudinal, structured real world patient data without compromising patient privacy.
SENSIGHT offers a suite of sophisticated AI research tools for synthetic control arms, cohort characterisation, disease progression, patient stratification, and image report analysis.
Access to the SENSIGHT platform is on an individual subscriber basis of £25,000 per person per year for commercial customers.
Analyse the feasibility of running synthetic control arms on specific patient data sets using Sensyne’s proprietary analytics tools.
Create new patient cohorts in specific research areas across large, diverse data sets efficiently, quickly and at scale.
Undertake patient stratification of cohorts to identify relevant sub-groups of patients using Sensyne’s proprietary deep clustering tools.
Perform medical image report analyses.
Analyse usage and outcomes by product or class across different health systems to understand real-world patient journeys.
We know patient data is precious so protecting it is our first priority. We never share data. We never sell data. Data never leaves Sensyne.
The platform instead rapidly interrogates Sensyne’s deep diverse datasets and delivers intelligent analytics and data-driven insights, not the data itself. . It does not allow SENSIGHT users access to any patient data directly.
With a simple subscription model, SENSIGHT is democratising health data and has the potential to accelerate clinical research. Individual researchers can analyse SENSIGHT data simply, easily and at pace.
Simple to use dashboard on a single platform that enables complex research queries to be easily and quickly navigated and understood.
© 2021 Sensyne Health plc. All rights reserved.
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives
